BRINZOLAMIDE

BRINZOLAMIDE was reported 4322 times

BRINZOLAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEEP ANTERIOR CHAMBER OF THE EYE 4 0.5000
1 URETERIC INJURY 10 0.1176
2 OCULAR PEMPHIGOID 4 0.0952
3 CORNEAL EPITHELIAL MICROCYSTS 2 0.0909
4 PYROGLUTAMATE INCREASED 8 0.0714
5 DEVICE DEPOSIT ISSUE 3 0.0556
6 PUNCTATE KERATITIS 23 0.0484
7 FLAT ANTERIOR CHAMBER OF EYE 7 0.0464
8 MALIGNANT NEOPLASM OF PLEURA 3 0.0435
9 INTRAOCULAR PRESSURE DECREASED 14 0.0423
10 OPTIC DISC HAEMORRHAGE 4 0.0417
11 OPTIC NERVE CUPPING 3 0.0400
12 ENOPHTHALMOS 3 0.0380
13 CILIARY HYPERAEMIA 2 0.0377
14 LENS DISLOCATION 4 0.0374
15 CHOROIDAL DETACHMENT 11 0.0369
16 NORMAL TENSION GLAUCOMA 3 0.0366
17 INTRAOCULAR PRESSURE FLUCTUATION 5 0.0360
18 ANTERIOR CHAMBER FIBRIN 3 0.0323
19 PANCREATIC NECROSIS 10 0.0314
20 EYELASH THICKENING 3 0.0312
21 CORNEAL INFECTION 4 0.0308
22 CILIARY BODY DISORDER 2 0.0294
23 INTRAOCULAR PRESSURE INCREASED 239 0.0293
24 FLOPPY IRIS SYNDROME 9 0.0286
25 INTRAOCULAR PRESSURE TEST ABNORMAL 11 0.0272
26 CORNEAL EPITHELIUM DEFECT 9 0.0271
27 GROWTH OF EYELASHES 17 0.0270
28 CORNEAL EROSION 10 0.0270
29 CORNEAL OEDEMA 33 0.0259
30 GLAUCOMA SURGERY 4 0.0247
31 CONJUNCTIVAL IRRITATION 2 0.0241
32 CATARACT CORTICAL 2 0.0227
33 PRODUCT DROPPER ISSUE 15 0.0211
34 HYPOTONY OF EYE 5 0.0210
35 EYELID MARGIN CRUSTING 19 0.0189
36 IRIS ADHESIONS 5 0.0185
37 IRIS HYPERPIGMENTATION 3 0.0179
38 SCLERAL DISORDER 3 0.0173
39 CORNEAL DISORDER 22 0.0171
40 STOMA SITE IRRITATION 3 0.0169
41 CONJUNCTIVITIS ALLERGIC 9 0.0162
42 CONJUNCTIVITIS BACTERIAL 3 0.0155
43 OPEN ANGLE GLAUCOMA 6 0.0147
44 GLAUCOMA 160 0.0143
45 CONJUNCTIVAL HYPERAEMIA 28 0.0139
46 EYE ALLERGY 10 0.0137
47 CORNEAL OPACITY 10 0.0134
48 HYPHAEMA 4 0.0132
49 CHONDROCALCINOSIS 3 0.0127
50 CORNEAL THINNING 2 0.0123
51 ANTERIOR CHAMBER CELL 3 0.0121
52 URETERAL DISORDER 3 0.0119
53 FOREIGN BODY SENSATION IN EYES 41 0.0119
54 BODY HEIGHT BELOW NORMAL 5 0.0118
55 EYE INFECTION BACTERIAL 3 0.0112
56 BLEPHARAL PIGMENTATION 4 0.0111
57 OPTIC NERVE INJURY 7 0.0109
58 CORNEAL DEPOSITS 5 0.0109
59 BLOOD MAGNESIUM ABNORMAL 3 0.0107
60 OROPHARYNGEAL SPASM 3 0.0106
61 INJURY CORNEAL 3 0.0105
62 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED DRUG 3 0.0101
63 EYELID DISORDER 14 0.0100
64 INTRAOCULAR LENS IMPLANT 3 0.0098
65 OCULAR HYPERTENSION 8 0.0095
66 CONJUNCTIVAL OEDEMA 6 0.0095
67 EYELID PAIN 6 0.0094
68 EYE COLOUR CHANGE 5 0.0094
69 ACQUIRED HAEMOPHILIA 4 0.0092
70 ANTERIOR CHAMBER INFLAMMATION 2 0.0086
71 PLEUROTHOTONUS 5 0.0084
72 DENTAL RESTORATION FAILURE 2 0.0084
73 ACQUIRED DIAPHRAGMATIC EVENTRATION 2 0.0084
74 MACULAR HOLE 7 0.0083
75 GASTRIC NEOPLASM 3 0.0083
76 RETINAL VASCULAR DISORDER 3 0.0082
77 SCLERAL HYPERAEMIA 5 0.0081
78 CATARACT NUCLEAR 3 0.0081
79 SWEAT GLAND DISORDER 3 0.0080
80 KERATITIS 13 0.0079
81 CORNEAL DYSTROPHY 2 0.0078
82 SMALL INTESTINAL HAEMORRHAGE 10 0.0077
83 EYELID IRRITATION 8 0.0076
84 SUPERFICIAL INJURY OF EYE 4 0.0076
85 EYE IRRITATION 191 0.0075
86 EYE OPERATION 13 0.0074
87 RETINAL INJURY 3 0.0073
88 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0072
89 CORNEAL SCAR 2 0.0071
90 BRONCHIAL OBSTRUCTION 6 0.0070
91 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0070
92 VISUAL FIELD DEFECT 35 0.0070
93 RETINAL VEIN OCCLUSION 12 0.0069
94 MACULAR OEDEMA 23 0.0068
95 PRODUCT DEPOSIT 4 0.0068
96 EYE DISCHARGE 33 0.0067
97 CYSTOID MACULAR OEDEMA 6 0.0067
98 ERYTHEMA OF EYELID 19 0.0067
99 AMAUROSIS FUGAX 3 0.0067
100 REACTION TO PRESERVATIVES 3 0.0066
101 PRODUCT CONTAINER SEAL ISSUE 3 0.0065
102 AORTIC DILATATION 4 0.0065
103 COLLAGEN DISORDER 2 0.0065
104 OPTIC NERVE DISORDER 7 0.0063
105 ULCERATIVE KERATITIS 10 0.0062
106 OCULAR HYPERAEMIA 141 0.0062
107 ESCHAR 3 0.0060
108 FOREIGN BODY IN EYE 3 0.0060
109 MACULAR FIBROSIS 3 0.0059
110 ACCIDENTAL POISONING 3 0.0058
111 HAEMORRHAGE URINARY TRACT 9 0.0058
112 CHOROIDAL EFFUSION 2 0.0058
113 EYE PAIN 155 0.0058
114 ASPIRATION PLEURAL CAVITY 3 0.0057
115 RETINAL ARTERY OCCLUSION 7 0.0056
116 CORONARY ANGIOPLASTY 2 0.0056
117 VOCAL CORD DISORDER 7 0.0055
118 DACRYOSTENOSIS ACQUIRED 3 0.0054
119 ENDOPHTHALMITIS 17 0.0053
120 BRONCHIAL CARCINOMA 3 0.0053
121 DEAFNESS TRANSITORY 3 0.0051
122 HERPES OPHTHALMIC 3 0.0051
123 STOMA SITE ERYTHEMA 3 0.0051
124 STOMA SITE HAEMORRHAGE 3 0.0051
125 DUODENAL ULCER HAEMORRHAGE 10 0.0050
126 ABNORMAL SENSATION IN EYE 15 0.0050
127 IRIDOCYCLITIS 7 0.0050
128 CORNEAL TRANSPLANT 2 0.0050
129 VITREOUS DETACHMENT 6 0.0049
130 CARDIAC INFECTION 2 0.0049
131 OPTIC ATROPHY 5 0.0048
132 OCULAR DISCOMFORT 17 0.0047
133 CARDIAC ANEURYSM 3 0.0047
134 ANGLE CLOSURE GLAUCOMA 8 0.0047
135 CHROMATOPSIA 3 0.0047
136 VENOUS OCCLUSION 6 0.0047
137 NASAL DISCHARGE DISCOLOURATION 3 0.0047
138 TOOTH INJURY 5 0.0046
139 EFFUSION 4 0.0046
140 VISUAL ACUITY REDUCED 125 0.0045
141 METAMORPHOPSIA 5 0.0045
142 PRODUCT RESIDUE PRESENT 4 0.0045
143 CHIKUNGUNYA VIRUS INFECTION 2 0.0045
144 CELLULITIS STAPHYLOCOCCAL 2 0.0045
145 EYE PRURITUS 60 0.0044
146 IRITIS 8 0.0044
147 EYE INJURY 6 0.0043
148 EYE INFLAMMATION 16 0.0042
149 EYELIDS PRURITUS 6 0.0042
150 CATARACT 123 0.0041
151 VITREOUS HAEMORRHAGE 7 0.0040
152 AXONAL NEUROPATHY 2 0.0040
153 BLEPHARITIS 7 0.0039
154 BLINDNESS UNILATERAL 33 0.0039
155 SCOTOMA 3 0.0039
156 MALIGNANT PLEURAL EFFUSION 4 0.0039
157 PUPIL FIXED 5 0.0038
158 CARTILAGE ATROPHY 2 0.0038
159 AGE-RELATED MACULAR DEGENERATION 3 0.0037
160 PRODUCT ADMINISTRATION ERROR 12 0.0037
161 DERMAL CYST 5 0.0037
162 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0037
163 MACULOPATHY 5 0.0036
164 CORNEAL ABRASION 3 0.0036
165 EYE INFECTION 19 0.0035
166 NIGHT BLINDNESS 3 0.0035
167 CEREBELLAR INFARCTION 4 0.0035
168 BLINDNESS 76 0.0035
169 HYPERAESTHESIA 19 0.0035
170 PYELONEPHRITIS ACUTE 4 0.0034
171 COLOUR BLINDNESS 2 0.0034
172 CHONDROCALCINOSIS PYROPHOSPHATE 2 0.0034
173 MEDICATION RESIDUE PRESENT 16 0.0033
174 CARDIAC FAILURE CHRONIC 6 0.0033
175 EAR CONGESTION 5 0.0033
176 BODY MASS INDEX INCREASED 2 0.0033
177 PRODUCT CONTAINER ISSUE 13 0.0032
178 DELAYED RECOVERY FROM ANAESTHESIA 2 0.0031
179 UVEITIS 16 0.0031
180 RETINAL OEDEMA 3 0.0031
181 LACRIMATION INCREASED 45 0.0031
182 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0030
183 LIP BLISTER 5 0.0030
184 RETINAL DETACHMENT 16 0.0030
185 CARDIAC DYSFUNCTION 2 0.0029
186 RETINAL TEAR 4 0.0029
187 ASTHENOPIA 9 0.0029
188 HORDEOLUM 4 0.0028
189 DRY EYE 53 0.0028
190 ALVEOLITIS ALLERGIC 3 0.0028
191 HALLUCINATIONS, MIXED 6 0.0028
192 EYELID OEDEMA 26 0.0028
193 PHARYNGEAL ERYTHEMA 4 0.0028
194 HYPERNATRAEMIA 8 0.0028
195 PERIODONTITIS 4 0.0027
196 MACULAR DEGENERATION 17 0.0027
197 BLOOD CHLORIDE INCREASED 3 0.0027
198 BUNION 2 0.0027
199 HYPERAEMIA 3 0.0027
200 IMMUNE THROMBOCYTOPENIC PURPURA 7 0.0026
201 HYPOTONIA 18 0.0026
202 BRONCHIAL HYPERREACTIVITY 2 0.0026
203 SCREAMING 11 0.0026
204 EOSINOPHILIC PNEUMONIA 4 0.0026
205 CAROTID ARTERY OCCLUSION 6 0.0025
206 VITREOUS FLOATERS 12 0.0025
207 INCREASED BRONCHIAL SECRETION 3 0.0025
208 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0025
209 INSTILLATION SITE PAIN 5 0.0025
210 ACUTE PRERENAL FAILURE 3 0.0025
211 BLOOD MAGNESIUM DECREASED 11 0.0025
212 EYE DISORDER 44 0.0025
213 HEPATIC CYST 5 0.0024
214 BRADYCARDIA 75 0.0023
215 CATARACT OPERATION 9 0.0023
216 METABOLIC ENCEPHALOPATHY 4 0.0023
217 PNEUMONIA STAPHYLOCOCCAL 3 0.0023
218 CATHETER SITE PAIN 3 0.0023
219 OPTIC ISCHAEMIC NEUROPATHY 4 0.0023
220 CONCOMITANT DISEASE AGGRAVATED 8 0.0023
221 BLOOD UREA DECREASED 2 0.0022
222 NASAL DRYNESS 8 0.0022
223 HYPOPNOEA 4 0.0022
224 PRODUCT PACKAGING QUANTITY ISSUE 7 0.0022
225 ANIMAL BITE 3 0.0021
226 EYE HAEMORRHAGE 18 0.0021
227 PANCREATITIS ACUTE 28 0.0021
228 STRABISMUS 4 0.0021
229 MYOPIA 3 0.0021
230 ORTHOSTATIC HYPOTENSION 21 0.0021
231 CLOSTRIDIUM COLITIS 2 0.0021
232 APNOEA 11 0.0020
233 CARDIAC FIBRILLATION 2 0.0020
234 MUSCLE RIGIDITY 14 0.0020
235 EYE SWELLING 43 0.0020
236 BLADDER NEOPLASM 2 0.0020
237 PHOTOPHOBIA 20 0.0020
238 VISION BLURRED 160 0.0020
239 AORTIC VALVE DISEASE 2 0.0020
240 BRADYPNOEA 2 0.0020
241 RETINAL HAEMORRHAGE 9 0.0019
242 DIABETIC RETINOPATHY 4 0.0019
243 MIOSIS 8 0.0019
244 VISUAL IMPAIRMENT 116 0.0019
245 EAR DISORDER 5 0.0019
246 EYELID PTOSIS 11 0.0019
247 ABSCESS LIMB 4 0.0019
248 WEIGHT BEARING DIFFICULTY 3 0.0019
249 CONJUNCTIVITIS 15 0.0019
250 BLINDNESS TRANSIENT 8 0.0018
251 KETOACIDOSIS 8 0.0018
252 ORGANISING PNEUMONIA 4 0.0018
253 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0018
254 RETINOPATHY 4 0.0018
255 SCLERODERMA 4 0.0018
256 PHOTOPSIA 7 0.0018
257 TENDON RUPTURE 15 0.0018
258 RETINAL DISORDER 3 0.0017
259 DYSLIPIDAEMIA 5 0.0017
260 HYPOACUSIS 31 0.0017
261 BRONCHOSPASM 16 0.0017
262 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0017
263 SKIN ATROPHY 5 0.0016
264 ONYCHOMADESIS 3 0.0016
265 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0016
266 PRODUCT AVAILABILITY ISSUE 3 0.0016
267 PHARYNGEAL DISORDER 3 0.0016
268 CHOLANGITIS 5 0.0016
269 CARDIAC FLUTTER 6 0.0016
270 PRODUCT PACKAGING ISSUE 7 0.0016
271 LEFT VENTRICULAR DYSFUNCTION 6 0.0016
272 ADENOCARCINOMA 2 0.0015
273 NEPHROGENIC ANAEMIA 4 0.0015
274 VENTRICULAR HYPOKINESIA 3 0.0015
275 BONE DENSITY ABNORMAL 2 0.0015
276 PANCREATIC CARCINOMA METASTATIC 3 0.0015
277 BUNDLE BRANCH BLOCK RIGHT 5 0.0015
278 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0015
279 UTERINE CANCER 3 0.0015
280 BLOOD PARATHYROID HORMONE INCREASED 3 0.0015
281 HAEMOGLOBIN INCREASED 3 0.0015
282 HYPOTHERMIA 9 0.0014
283 ASPHYXIA 6 0.0014
284 RENAL CANCER 6 0.0014
285 INCREASED UPPER AIRWAY SECRETION 6 0.0014
286 REACTION TO DRUG EXCIPIENTS 3 0.0014
287 EPIGASTRIC DISCOMFORT 3 0.0013
288 LOCALISED OEDEMA 4 0.0013
289 WOUND 14 0.0013
290 CHEST X-RAY ABNORMAL 3 0.0013
291 SKIN HYPERPIGMENTATION 6 0.0013
292 HAEMORRHAGIC STROKE 7 0.0013
293 HYPERCALCAEMIA 9 0.0013
294 PEMPHIGOID 4 0.0013
295 AORTIC ARTERIOSCLEROSIS 2 0.0013
296 ACTINIC KERATOSIS 2 0.0013
297 FACIAL PARESIS 3 0.0013
298 PERIORBITAL OEDEMA 4 0.0012
299 EXTRASYSTOLES 6 0.0012
300 INCORRECT DOSAGE ADMINISTERED 3 0.0012
301 BREATH ODOUR 2 0.0012
302 BREATH SOUNDS ABNORMAL 3 0.0012
303 DEAFNESS 17 0.0012
304 CONJUNCTIVAL HAEMORRHAGE 3 0.0012
305 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0012
306 HYPOPHAGIA 17 0.0012
307 ABNORMAL LOSS OF WEIGHT 5 0.0012
308 GENERALISED OEDEMA 9 0.0012
309 HAEMORRHAGE INTRACRANIAL 13 0.0012
310 MELAENA 17 0.0012
311 PALLOR 18 0.0012
312 NAIL DISORDER 5 0.0012
313 HYPOKALAEMIA 31 0.0012
314 MUSCLE HAEMORRHAGE 3 0.0012
315 GINGIVAL DISORDER 3 0.0012
316 VENOUS THROMBOSIS 3 0.0012
317 PERIPHERAL ISCHAEMIA 3 0.0011
318 BLOOD CREATININE ABNORMAL 2 0.0011
319 DEMENTIA ALZHEIMER'S TYPE 2 0.0011
320 RHINITIS 5 0.0011
321 CAROTID ARTERY STENOSIS 3 0.0011
322 WHEEZING 30 0.0011
323 COMA SCALE ABNORMAL 2 0.0011
324 BREAST CANCER RECURRENT 2 0.0011
325 HEART RATE DECREASED 20 0.0011
326 PHLEBITIS 4 0.0011
327 URINE ODOUR ABNORMAL 4 0.0011
328 CARDIOGENIC SHOCK 8 0.0011
329 GASTROINTESTINAL MOTILITY DISORDER 3 0.0011
330 HEART RATE IRREGULAR 16 0.0011
331 CIRCULATORY COLLAPSE 13 0.0011
332 RESPIRATION ABNORMAL 3 0.0011
333 DIPLOPIA 17 0.0011
334 MONOPLEGIA 3 0.0011
335 ASTHMATIC CRISIS 2 0.0011
336 DIVERTICULUM INTESTINAL 3 0.0011
337 TIBIA FRACTURE 3 0.0011
338 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0011
339 UNRESPONSIVE TO STIMULI 17 0.0011
340 COMPRESSION FRACTURE 3 0.0011
341 FUNGAL INFECTION 20 0.0011
342 APPLICATION SITE URTICARIA 2 0.0011
343 HYPONATRAEMIA 36 0.0011
344 HAEMORRHAGIC ANAEMIA 5 0.0011
345 ACUTE RESPIRATORY FAILURE 10 0.0010
346 DIVERTICULUM 6 0.0010
347 CEREBRAL ISCHAEMIA 4 0.0010
348 SUBDURAL HAEMATOMA 10 0.0010
349 SALIVARY HYPERSECRETION 6 0.0010
350 ATRIAL FIBRILLATION 57 0.0010
351 EPISTAXIS 47 0.0010
352 AORTIC VALVE INCOMPETENCE 3 0.0010
353 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0010
354 INFARCTION 5 0.0010
355 SKIN DISCOLOURATION 27 0.0010
356 EXPIRED DRUG ADMINISTERED 5 0.0010
357 CREPITATIONS 2 0.0010
358 TENSION 4 0.0010
359 MUSCLE ATROPHY 7 0.0010
360 AGEUSIA 14 0.0010
361 LARGE INTESTINE POLYP 4 0.0010
362 FEMORAL NECK FRACTURE 3 0.0010
363 DYSPHONIA 32 0.0010
364 ELECTROCARDIOGRAM ABNORMAL 5 0.0010
365 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0010
366 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0010
367 PNEUMONIA ASPIRATION 14 0.0010
368 SCAB 6 0.0010
369 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0010
370 ASTHMA 45 0.0010
371 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0010
372 PETIT MAL EPILEPSY 3 0.0010
373 ARRHYTHMIA 29 0.0010
374 GRIP STRENGTH DECREASED 3 0.0009
375 DRY MOUTH 45 0.0009
376 SPINAL COMPRESSION FRACTURE 5 0.0009
377 MALNUTRITION 6 0.0009
378 PRODUCT USE COMPLAINT 3 0.0009
379 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0009
380 BLOOD UREA INCREASED 12 0.0009
381 MOUTH HAEMORRHAGE 4 0.0009
382 CEREBRAL HAEMATOMA 2 0.0009
383 MENTAL STATUS CHANGES 17 0.0009
384 SCRATCH 4 0.0009
385 DEAFNESS UNILATERAL 3 0.0009
386 CARDIAC FAILURE ACUTE 3 0.0009
387 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0009
388 HAIR GROWTH ABNORMAL 4 0.0009
389 HAEMOGLOBIN DECREASED 57 0.0009
390 ECZEMA 11 0.0009
391 THROAT IRRITATION 22 0.0009
392 CHOKING SENSATION 3 0.0009
393 PELVIC FRACTURE 4 0.0009
394 HIATUS HERNIA 8 0.0009
395 BLOOD CALCIUM INCREASED 5 0.0009
396 COMMUNICATION DISORDER 2 0.0009
397 SNEEZING 10 0.0009
398 EPILEPSY 14 0.0009
399 SYNCOPE 53 0.0009
400 MADAROSIS 7 0.0008
401 INTESTINAL HAEMORRHAGE 3 0.0008
402 PRODUCT ODOUR ABNORMAL 4 0.0008
403 BACTERAEMIA 5 0.0008
404 ORAL CANDIDIASIS 6 0.0008
405 PERIPHERAL COLDNESS 7 0.0008
406 THYROID DISORDER 7 0.0008
407 PROSTATE CANCER 9 0.0008
408 DYSGEUSIA 41 0.0008
409 MIDDLE INSOMNIA 9 0.0008
410 DEVICE OCCLUSION 3 0.0008
411 HYPERTHERMIA 4 0.0008
412 EAR PAIN 9 0.0008
413 JAUNDICE 16 0.0008
414 RENAL PAIN 5 0.0008
415 MULTIPLE ALLERGIES 3 0.0008
416 ENCEPHALITIS 3 0.0008
417 GINGIVAL PAIN 4 0.0008
418 COAGULOPATHY 9 0.0008
419 PNEUMOTHORAX 7 0.0008
420 TENDERNESS 5 0.0008
421 CARDIAC VALVE DISEASE 3 0.0008
422 FAILURE TO THRIVE 3 0.0008
423 AZOTAEMIA 2 0.0008
424 POOR VENOUS ACCESS 3 0.0008
425 BODY HEIGHT DECREASED 6 0.0008
426 PHARYNGITIS 6 0.0008
427 HYPOGLYCAEMIA 25 0.0008
428 PRESYNCOPE 11 0.0008
429 CARDIAC PACEMAKER INSERTION 3 0.0008
430 NOCTURIA 5 0.0008
431 HYPERCHOLESTEROLAEMIA 4 0.0008
432 MYDRIASIS 6 0.0008
433 CREATININE RENAL CLEARANCE DECREASED 2 0.0008
434 BLOOD CHOLESTEROL ABNORMAL 2 0.0008
435 ACUTE KIDNEY INJURY 52 0.0008
436 SEPTIC SHOCK 18 0.0008
437 ULCER 7 0.0008
438 RHINORRHOEA 25 0.0008
439 RESPIRATORY TRACT CONGESTION 7 0.0008
440 PULMONARY CONGESTION 6 0.0008
441 MICTURITION URGENCY 5 0.0008
442 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0008
443 SENSATION OF HEAVINESS 3 0.0008
444 DYSGRAPHIA 3 0.0008
445 CHAPPED LIPS 2 0.0008
446 VITAMIN D DEFICIENCY 4 0.0007
447 BLEPHAROSPASM 2 0.0007
448 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0007
449 HYPOXIA 14 0.0007
450 ATELECTASIS 5 0.0007
451 C-REACTIVE PROTEIN INCREASED 13 0.0007
452 SINUS CONGESTION 6 0.0007
453 CONFUSIONAL STATE 73 0.0007
454 GASTRIC ULCER HAEMORRHAGE 3 0.0007
455 HALLUCINATION, VISUAL 8 0.0007
456 LYMPHOMA 6 0.0007
457 SOPOR 6 0.0007
458 TENDON DISORDER 3 0.0007
459 BACTERIAL INFECTION 7 0.0007
460 HYPERTENSION 87 0.0007
461 BLOOD PRESSURE FLUCTUATION 8 0.0007
462 OESOPHAGITIS 5 0.0007
463 TINNITUS 20 0.0007
464 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0007
465 CANDIDIASIS 3 0.0007
466 BLOOD CREATININE INCREASED 29 0.0007
467 ASTHENIA 157 0.0007
468 HYPOKINESIA 6 0.0007
469 PULMONARY FIBROSIS 7 0.0007
470 HEAD DISCOMFORT 6 0.0007
471 GANGRENE 3 0.0007
472 PLATELET COUNT INCREASED 5 0.0007
473 DRY THROAT 4 0.0007
474 HYPERSENSITIVITY 69 0.0007
475 JOINT INJURY 8 0.0007
476 PAROSMIA 3 0.0007
477 SWELLING 32 0.0007
478 ACUTE CORONARY SYNDROME 4 0.0007
479 FALL 131 0.0007
480 HYPERTONIA 3 0.0007
481 APATHY 6 0.0007
482 MUSCULAR WEAKNESS 47 0.0007
483 THROAT TIGHTNESS 11 0.0007
484 PARALYSIS 6 0.0007
485 EXPIRED PRODUCT ADMINISTERED 12 0.0007
486 URINARY RETENTION 13 0.0007
487 ERYTHEMA MULTIFORME 4 0.0007
488 HEARING IMPAIRED 4 0.0007
489 MUSCULOSKELETAL CHEST PAIN 6 0.0007
490 AORTIC DISSECTION 2 0.0007
491 SINUS BRADYCARDIA 4 0.0007
492 GASTRITIS 11 0.0007
493 SWELLING FACE 26 0.0007
494 UPPER LIMB FRACTURE 8 0.0007
495 FEELING COLD 11 0.0007
496 LUNG INFECTION 11 0.0007
497 DIZZINESS POSTURAL 3 0.0007
498 TRANSFUSION 4 0.0007
499 EOSINOPHILIA 6 0.0007
500 PSYCHIATRIC SYMPTOM 3 0.0007
501 VISUAL DISTURBANCE 4 0.0007
502 DUODENAL ULCER 3 0.0006
503 DYSPNOEA 210 0.0006
504 ANEURYSM 2 0.0006
505 TREATMENT FAILURE 13 0.0006
506 HYPOAESTHESIA ORAL 6 0.0006
507 HAEMATOCRIT DECREASED 9 0.0006
508 RED BLOOD CELL COUNT DECREASED 10 0.0006
509 DISTURBANCE IN ATTENTION 22 0.0006
510 RENAL FAILURE ACUTE 28 0.0006
511 ATRIOVENTRICULAR BLOCK 3 0.0006
512 LIVER DISORDER 16 0.0006
513 RESPIRATORY DISORDER 11 0.0006
514 DYSPHAGIA 35 0.0006
515 FOOT FRACTURE 7 0.0006
516 TRANSIENT ISCHAEMIC ATTACK 15 0.0006
517 FULL BLOOD COUNT DECREASED 6 0.0006
518 HICCUPS 3 0.0006
519 APPLICATION SITE DISCOLOURATION 2 0.0006
520 AUTOIMMUNE DISORDER 2 0.0006
521 AGRANULOCYTOSIS 6 0.0006
522 PHOTOSENSITIVITY REACTION 6 0.0006
523 DEMENTIA 8 0.0006
524 LIPASE INCREASED 3 0.0006
525 ACCIDENTAL EXPOSURE TO PRODUCT 16 0.0006
526 PHARYNGEAL OEDEMA 9 0.0006
527 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0006
528 BALANCE DISORDER 32 0.0006
529 VERTIGO 23 0.0006
530 MASS 5 0.0006
531 ANAPHYLACTIC REACTION 17 0.0006
532 BLOOD CHOLESTEROL INCREASED 17 0.0006
533 BOWEL MOVEMENT IRREGULARITY 2 0.0006
534 DECREASED ACTIVITY 3 0.0006
535 BENIGN PROSTATIC HYPERPLASIA 2 0.0006
536 DIABETES MELLITUS 29 0.0006
537 JOINT SWELLING 34 0.0006
538 BREAST CANCER FEMALE 9 0.0006
539 VITAMIN D DECREASED 3 0.0006
540 RENAL IMPAIRMENT 25 0.0006
541 LUNG NEOPLASM MALIGNANT 9 0.0006
542 BLOOD PRESSURE INCREASED 50 0.0006
543 TUBULOINTERSTITIAL NEPHRITIS 6 0.0006
544 TENDONITIS 6 0.0006
545 OROPHARYNGEAL PAIN 29 0.0006
546 LOSS OF CONSCIOUSNESS 47 0.0006
547 PALPITATIONS 41 0.0006
548 TACHYCARDIA 30 0.0006
549 DYSSTASIA 10 0.0006
550 PRODUCT TASTE ABNORMAL 4 0.0006
551 CYTOLYTIC HEPATITIS 2 0.0006
552 MULTIPLE MYELOMA 3 0.0006
553 HYPERKALAEMIA 12 0.0006
554 LETHARGY 21 0.0006
555 MYALGIA 60 0.0006
556 DISABILITY 4 0.0006
557 TOXIC EPIDERMAL NECROLYSIS 5 0.0006
558 HAEMORRHOIDS 7 0.0006
559 BRONCHOPNEUMONIA 2 0.0006
560 BLOOD POTASSIUM DECREASED 10 0.0006
561 ANGINA PECTORIS 11 0.0006
562 ARTERIAL OCCLUSIVE DISEASE 3 0.0006
563 SQUAMOUS CELL CARCINOMA 3 0.0006
564 HYPOTENSION 64 0.0006
565 CHEST DISCOMFORT 31 0.0006
566 STENT PLACEMENT 3 0.0005
567 ANAEMIA 64 0.0005
568 HAEMATEMESIS 9 0.0005
569 METASTASES TO LIVER 5 0.0005
570 SEASONAL ALLERGY 3 0.0005
571 LIMB INJURY 7 0.0005
572 DRUG INTOLERANCE 22 0.0005
573 HEMIPLEGIA 3 0.0005
574 SOMNOLENCE 64 0.0005
575 PRURITUS GENERALISED 12 0.0005
576 URINARY INCONTINENCE 10 0.0005
577 RECTAL HAEMORRHAGE 15 0.0005
578 RENAL DISORDER 14 0.0005
579 SPINAL PAIN 3 0.0005
580 GLOSSODYNIA 5 0.0005
581 LUNG DISORDER 14 0.0005
582 NASOPHARYNGITIS 52 0.0005
583 CARDIOMEGALY 5 0.0005
584 EAR DISCOMFORT 3 0.0005
585 BLOOD SODIUM DECREASED 6 0.0005
586 PULMONARY ARTERIAL HYPERTENSION 5 0.0005
587 CONTUSION 29 0.0005
588 RESPIRATORY TRACT INFECTION 7 0.0005
589 SPEECH DISORDER 17 0.0005
590 SHOCK 7 0.0005
591 COUGH 74 0.0005
592 THIRST 5 0.0005
593 CEREBRAL HAEMORRHAGE 12 0.0005
594 NIGHTMARE 12 0.0005
595 RIB FRACTURE 6 0.0005
596 HAEMOPTYSIS 9 0.0005
597 PRODUCT QUALITY ISSUE 53 0.0005
598 IMPAIRED DRIVING ABILITY 4 0.0005
599 FAECES DISCOLOURED 7 0.0005
600 CONDITION AGGRAVATED 66 0.0005
601 CORONARY ARTERY DISEASE 13 0.0005
602 NASAL CONGESTION 15 0.0005
603 DYSPEPSIA 29 0.0005
604 DRUG INEFFECTIVE 342 0.0005
605 BLOOD PRESSURE DECREASED 20 0.0005
606 FOOT DEFORMITY 3 0.0005
607 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0005
608 CHRONIC KIDNEY DISEASE 21 0.0005
609 DERMATITIS 5 0.0005
610 BLADDER DISORDER 3 0.0005
611 SEIZURE 24 0.0005
612 GASTROINTESTINAL HAEMORRHAGE 32 0.0005
613 DIZZINESS 148 0.0005
614 BLOOD URINE PRESENT 6 0.0005
615 FEAR 10 0.0005
616 ACCIDENT 3 0.0005
617 SWOLLEN TONGUE 10 0.0005
618 HEAD INJURY 9 0.0005
619 MUSCLE TIGHTNESS 5 0.0005
620 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0005
621 GAIT DISTURBANCE 56 0.0005
622 GOUT 5 0.0005
623 OSTEOMYELITIS 6 0.0005
624 BLOOD GLUCOSE DECREASED 16 0.0005
625 DYSPNOEA EXERTIONAL 9 0.0005
626 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0005
627 DYSURIA 11 0.0005
628 SUBARACHNOID HAEMORRHAGE 3 0.0005
629 CORONARY ARTERY OCCLUSION 5 0.0005
630 BREAST MASS 2 0.0005
631 CARDIAC DISORDER 27 0.0005
632 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0005
633 EXTRAPYRAMIDAL DISORDER 10 0.0005
634 CYANOSIS 5 0.0005
635 RASH PRURITIC 14 0.0005
636 DRUG HYPERSENSITIVITY 55 0.0005
637 SLEEP DISORDER 16 0.0005
638 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0005
639 PETECHIAE 3 0.0005
640 BLISTER 14 0.0005
641 SKIN ULCER 7 0.0005
642 MALAISE 126 0.0005
643 DRUG INTERACTION 44 0.0005
644 NECK PAIN 15 0.0005
645 CARDIAC MURMUR 3 0.0005
646 NO ADVERSE EVENT 32 0.0005
647 EMPHYSEMA 3 0.0005
648 MUSCULOSKELETAL STIFFNESS 21 0.0005
649 VASCULITIS 3 0.0005
650 PRESCRIBED OVERDOSE 5 0.0005
651 DRUG DISPENSING ERROR 7 0.0005
652 DRUG ADMINISTRATION ERROR 14 0.0005
653 HEPATIC STEATOSIS 5 0.0005
654 LIP SWELLING 9 0.0005
655 PAIN IN EXTREMITY 81 0.0004
656 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0004
657 MYOCARDIAL ISCHAEMIA 4 0.0004
658 PRODUCT SUBSTITUTION ISSUE 15 0.0004
659 OEDEMA PERIPHERAL 39 0.0004
660 PLEURAL EFFUSION 17 0.0004
661 HEADACHE 162 0.0004
662 SEXUAL DYSFUNCTION 3 0.0004
663 HIP FRACTURE 8 0.0004
664 END STAGE RENAL DISEASE 5 0.0004
665 MUSCULOSKELETAL PAIN 18 0.0004
666 DISORIENTATION 12 0.0004
667 FREQUENT BOWEL MOVEMENTS 5 0.0004
668 URINARY TRACT INFECTION 40 0.0004
669 BONE DENSITY DECREASED 3 0.0004
670 HEPATOMEGALY 3 0.0004
671 HEMIPARESIS 5 0.0004
672 BLOOD PRESSURE ABNORMAL 4 0.0004
673 WRIST FRACTURE 3 0.0004
674 CEREBRAL INFARCTION 7 0.0004
675 THROMBOSIS 20 0.0004
676 INTERSTITIAL LUNG DISEASE 11 0.0004
677 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0004
678 HYPERTENSIVE CRISIS 3 0.0004
679 ANGER 10 0.0004
680 AFFECT LABILITY 3 0.0004
681 FRACTURE 4 0.0004
682 HAIR TEXTURE ABNORMAL 4 0.0004
683 LOWER RESPIRATORY TRACT INFECTION 9 0.0004
684 DRUG ERUPTION 4 0.0004
685 INCORRECT DOSE ADMINISTERED 37 0.0004
686 TACHYPNOEA 3 0.0004
687 CHEST PAIN 51 0.0004
688 HAEMATOCHEZIA 11 0.0004
689 METABOLIC ACIDOSIS 7 0.0004
690 DIARRHOEA 141 0.0004
691 HALLUCINATION 17 0.0004
692 AMNESIA 18 0.0004
693 LACERATION 4 0.0004
694 ELECTROCARDIOGRAM QT PROLONGED 8 0.0004
695 MUSCULOSKELETAL DISCOMFORT 4 0.0004
696 BLOOD COUNT ABNORMAL 4 0.0004
697 GASTRIC DISORDER 10 0.0004
698 PROTEINURIA 4 0.0004
699 BREAST PAIN 3 0.0004
700 SKIN DISORDER 7 0.0004
701 PRODUCT STORAGE ERROR 6 0.0004
702 ABDOMINAL DISCOMFORT 35 0.0004
703 ERUCTATION 4 0.0004
704 ERYTHEMA 47 0.0004
705 RASH PAPULAR 6 0.0004
706 CARDIOMYOPATHY 4 0.0004
707 APHAGIA 2 0.0004
708 BURNING SENSATION 18 0.0004
709 RASH GENERALISED 11 0.0004
710 FATIGUE 170 0.0004
711 CYSTITIS 8 0.0004
712 NERVOUSNESS 15 0.0004
713 CARDIAC FAILURE CONGESTIVE 27 0.0004
714 BODY TEMPERATURE INCREASED 5 0.0004
715 CARDIAC FAILURE 19 0.0004
716 PNEUMONIA 72 0.0004
717 PRODUCTIVE COUGH 9 0.0004
718 HAEMATOMA 7 0.0004
719 FIBROMYALGIA 5 0.0004
720 OXYGEN SATURATION DECREASED 10 0.0004
721 GASTRIC ULCER 5 0.0004
722 NIGHT SWEATS 7 0.0004
723 DEHYDRATION 34 0.0004
724 POLLAKIURIA 10 0.0004
725 PULMONARY OEDEMA 11 0.0004
726 PERIPHERAL SWELLING 27 0.0004
727 NEURALGIA 5 0.0004
728 HEPATITIS 6 0.0004
729 VENTRICULAR FIBRILLATION 3 0.0004
730 FLATULENCE 13 0.0004
731 PANIC ATTACK 9 0.0004
732 MOBILITY DECREASED 15 0.0004
733 BONE PAIN 14 0.0004
734 COLITIS 7 0.0004
735 ATAXIA 3 0.0004
736 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
737 CELLULITIS 12 0.0004
738 KIDNEY INFECTION 4 0.0004
739 GINGIVAL BLEEDING 3 0.0004
740 HEART RATE INCREASED 22 0.0004
741 DISEASE RECURRENCE 5 0.0004
742 PAIN IN JAW 7 0.0004
743 SCAR 4 0.0004
744 PERICARDIAL EFFUSION 5 0.0004
745 FEELING HOT 14 0.0004
746 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0004
747 RENAL INJURY 6 0.0004
748 POST PROCEDURAL HAEMORRHAGE 3 0.0004
749 NEPHROLITHIASIS 9 0.0004
750 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0004
751 COORDINATION ABNORMAL 4 0.0004
752 RENAL FAILURE CHRONIC 3 0.0004
753 INCORRECT PRODUCT STORAGE 5 0.0004
754 SPINAL FRACTURE 4 0.0004
755 BLOOD GLUCOSE ABNORMAL 4 0.0004
756 ABDOMINAL PAIN LOWER 6 0.0004
757 CARPAL TUNNEL SYNDROME 3 0.0004
758 SINUSITIS 21 0.0004
759 TOOTH EXTRACTION 3 0.0004
760 BLOOD ALBUMIN DECREASED 2 0.0004
761 PARAESTHESIA ORAL 3 0.0004
762 CHOKING 4 0.0004
763 PAIN 113 0.0004
764 OEDEMA 12 0.0004
765 HAIR COLOUR CHANGES 3 0.0004
766 BACK PAIN 50 0.0004
767 HYPOTHYROIDISM 6 0.0004
768 CEREBROVASCULAR ACCIDENT 42 0.0004
769 ABDOMINAL PAIN UPPER 42 0.0004
770 SEDATION 5 0.0004
771 NEOPLASM MALIGNANT 10 0.0004
772 DYSKINESIA 9 0.0004
773 CONSTIPATION 40 0.0004
774 HYPERGLYCAEMIA 8 0.0004
775 BRONCHITIS 17 0.0004
776 INTERVERTEBRAL DISC PROTRUSION 5 0.0004
777 ARTHRALGIA 74 0.0004
778 MOVEMENT DISORDER 7 0.0004
779 THROMBOCYTOPENIA 22 0.0004
780 STOMATITIS 11 0.0003
781 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0003
782 SLEEP APNOEA SYNDROME 4 0.0003
783 SKIN LESION 5 0.0003
784 ALOPECIA 39 0.0003
785 ACCIDENTAL OVERDOSE 7 0.0003
786 CHROMATURIA 5 0.0003
787 NEOPLASM PROGRESSION 5 0.0003
788 PRESCRIBED UNDERDOSE 3 0.0003
789 RASH ERYTHEMATOUS 8 0.0003
790 DRUG LEVEL INCREASED 3 0.0003
791 HOT FLUSH 13 0.0003
792 ANKLE FRACTURE 3 0.0003
793 ANURIA 2 0.0003
794 HYPERLIPIDAEMIA 3 0.0003
795 ABDOMINAL PAIN 45 0.0003
796 DYSARTHRIA 8 0.0003
797 DISEASE PROGRESSION 19 0.0003
798 RENAL FAILURE 28 0.0003
799 VIRAL INFECTION 6 0.0003
800 ARTHROPATHY 9 0.0003
801 OFF LABEL USE 94 0.0003
802 LACTIC ACIDOSIS 5 0.0003
803 PRURITUS 57 0.0003
804 FEMUR FRACTURE 7 0.0003
805 DISCOMFORT 8 0.0003
806 BONE MARROW FAILURE 5 0.0003
807 PYREXIA 64 0.0003
808 MEMORY IMPAIRMENT 25 0.0003
809 ABASIA 8 0.0003
810 STAPHYLOCOCCAL INFECTION 7 0.0003
811 CHOLELITHIASIS 7 0.0003
812 WHITE BLOOD CELL COUNT INCREASED 8 0.0003
813 TREMOR 33 0.0003
814 FEELING ABNORMAL 47 0.0003
815 PANCYTOPENIA 10 0.0003
816 TRANSAMINASES INCREASED 4 0.0003
817 CRYING 8 0.0003
818 ARTHRITIS 13 0.0003
819 MUSCLE SPASMS 35 0.0003
820 COMA 9 0.0003
821 OSTEOPOROSIS 6 0.0003
822 DEPRESSION 46 0.0003
823 INFLAMMATION 7 0.0003
824 BLOOD GLUCOSE INCREASED 38 0.0003
825 DECREASED APPETITE 37 0.0003
826 WHITE BLOOD CELL COUNT DECREASED 17 0.0003
827 MYOCARDIAL INFARCTION 41 0.0003
828 HERNIA 3 0.0003
829 BLADDER CANCER 4 0.0003
830 GASTROENTERITIS VIRAL 3 0.0003
831 ORAL PAIN 4 0.0003
832 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0003
833 MEDICATION ERROR 11 0.0003
834 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0003
835 MOOD ALTERED 5 0.0003
836 BLOOD CALCIUM DECREASED 2 0.0003
837 CHILLS 20 0.0003
838 TOOTH DISORDER 4 0.0003
839 PULMONARY HYPERTENSION 4 0.0003
840 IRRITABLE BOWEL SYNDROME 3 0.0003
841 NEUROPATHY PERIPHERAL 13 0.0003
842 HYPOAESTHESIA 26 0.0003
843 CHOLESTASIS 3 0.0003
844 CHOLECYSTECTOMY 2 0.0003
845 INTENTIONAL DRUG MISUSE 6 0.0003
846 LEUKOPENIA 8 0.0003
847 PARAESTHESIA 27 0.0003
848 ALANINE AMINOTRANSFERASE INCREASED 11 0.0003
849 VOMITING 75 0.0003
850 APHONIA 2 0.0003
851 FACE OEDEMA 3 0.0003
852 BLOOD BILIRUBIN INCREASED 5 0.0003
853 MENTAL IMPAIRMENT 4 0.0003
854 RESTLESS LEGS SYNDROME 3 0.0003
855 RASH 60 0.0003
856 PRODUCT DOSE OMISSION 11 0.0003
857 INJECTION SITE HAEMORRHAGE 11 0.0003
858 INSOMNIA 45 0.0003
859 COLD SWEAT 3 0.0003
860 ABDOMINAL DISTENSION 16 0.0003
861 THERAPEUTIC RESPONSE DECREASED 9 0.0003
862 APHASIA 5 0.0003
863 HAEMATURIA 6 0.0003
864 DRUG-INDUCED LIVER INJURY 3 0.0003
865 POOR QUALITY SLEEP 3 0.0003
866 ADVERSE REACTION 2 0.0003
867 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0003
868 UPPER RESPIRATORY TRACT INFECTION 7 0.0003
869 FLUID RETENTION 8 0.0003
870 CHOLECYSTITIS 2 0.0003
871 ABNORMAL BEHAVIOUR 8 0.0003
872 DIVERTICULITIS 4 0.0003
873 HYPERHIDROSIS 21 0.0003
874 AGGRESSION 9 0.0003
875 CARDIAC ARREST 14 0.0003
876 PRODUCT USE ISSUE 23 0.0003
877 DRUG PRESCRIBING ERROR 5 0.0003
878 STEVENS-JOHNSON SYNDROME 4 0.0003
879 BEDRIDDEN 2 0.0003
880 HERPES ZOSTER 8 0.0003
881 LIMB DISCOMFORT 4 0.0003
882 ECONOMIC PROBLEM 3 0.0003
883 WEIGHT DECREASED 39 0.0002
884 HEPATIC FUNCTION ABNORMAL 5 0.0002
885 NAUSEA 114 0.0002
886 ANXIETY 42 0.0002
887 LYMPHADENOPATHY 5 0.0002
888 DEPRESSED MOOD 7 0.0002
889 EATING DISORDER 3 0.0002
890 TOXICITY TO VARIOUS AGENTS 21 0.0002
891 GALLBLADDER DISORDER 3 0.0002
892 ACUTE MYOCARDIAL INFARCTION 5 0.0002
893 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0002
894 INFECTION 17 0.0002
895 PNEUMONITIS 3 0.0002
896 INTENTIONAL PRODUCT USE ISSUE 5 0.0002
897 COGNITIVE DISORDER 6 0.0002
898 LOCALISED INFECTION 3 0.0002
899 PANCREATITIS 8 0.0002
900 HAEMORRHAGE 14 0.0002
901 RESPIRATORY DISTRESS 4 0.0002
902 DEEP VEIN THROMBOSIS 11 0.0002
903 LOCAL SWELLING 4 0.0002
904 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
905 NEUTROPENIA 14 0.0002
906 SEPSIS 15 0.0002
907 ENCEPHALOPATHY 3 0.0002
908 THERAPY NON-RESPONDER 3 0.0002
909 OSTEONECROSIS OF JAW 4 0.0002
910 OVERDOSE 21 0.0002
911 IRRITABILITY 9 0.0002
912 FEBRILE NEUTROPENIA 7 0.0002
913 ANAPHYLACTIC SHOCK 3 0.0002
914 OSTEONECROSIS 4 0.0002
915 MENTAL DISORDER 5 0.0002
916 BACK DISORDER 2 0.0002
917 PLATELET COUNT DECREASED 12 0.0002
918 GASTROINTESTINAL DISORDER 8 0.0002
919 INJECTION SITE PAIN 33 0.0002
920 MIGRAINE 10 0.0002
921 JOINT STIFFNESS 3 0.0002
922 CARDIO-RESPIRATORY ARREST 6 0.0002
923 DEVICE ISSUE 6 0.0002
924 WEIGHT INCREASED 25 0.0002
925 INJECTION SITE BRUISING 9 0.0002
926 APPLICATION SITE RASH 2 0.0002
927 ANGIOEDEMA 5 0.0002
928 BLOOD POTASSIUM INCREASED 2 0.0002
929 DRY SKIN 11 0.0002
930 ILL-DEFINED DISORDER 4 0.0002
931 COLITIS ULCERATIVE 3 0.0002
932 INFLUENZA 11 0.0002
933 RESPIRATORY ARREST 4 0.0002
934 SKIN BURNING SENSATION 7 0.0002
935 RHABDOMYOLYSIS 5 0.0002
936 DRUG EFFECT INCOMPLETE 7 0.0002
937 STRESS 7 0.0002
938 URTICARIA 17 0.0002
939 SKIN IRRITATION 4 0.0002
940 HYPERSOMNIA 3 0.0002
941 PULMONARY EMBOLISM 12 0.0002
942 LABORATORY TEST ABNORMAL 3 0.0002
943 INJURY 9 0.0002
944 TYPE 2 DIABETES MELLITUS 4 0.0002
945 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0002
946 BREAST CANCER 6 0.0002
947 SKIN EXFOLIATION 7 0.0002
948 THERAPY CESSATION 4 0.0002
949 HEPATIC ENZYME INCREASED 6 0.0002
950 INFLUENZA LIKE ILLNESS 10 0.0002
951 RESTLESSNESS 4 0.0002
952 ALTERED STATE OF CONSCIOUSNESS 2 0.0002
953 UNDERDOSE 7 0.0002
954 RASH MACULAR 3 0.0002
955 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0002
956 INJECTION SITE MASS 3 0.0002
957 PRODUCT USE IN UNAPPROVED INDICATION 11 0.0002
958 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
959 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0002
960 AGITATION 8 0.0002
961 DEATH 70 0.0002
962 NEUTROPHIL COUNT DECREASED 3 0.0002
963 PSYCHOTIC DISORDER 3 0.0002
964 RESPIRATORY FAILURE 7 0.0002
965 RHEUMATOID ARTHRITIS 8 0.0002
966 HEPATIC FAILURE 3 0.0002
967 INFUSION RELATED REACTION 4 0.0002
968 INTENTIONAL PRODUCT MISUSE 7 0.0001
969 ANOREXIA 2 0.0001
970 CARDIOVASCULAR DISORDER 3 0.0001
971 DRUG EFFECT DECREASED 8 0.0001
972 MALIGNANT NEOPLASM PROGRESSION 7 0.0001
973 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
974 CONVULSION 8 0.0001
975 LIVER FUNCTION TEST ABNORMAL 3 0.0001
976 FLUSHING 9 0.0001
977 HOSPITALISATION 8 0.0001
978 ADVERSE EVENT 7 0.0001
979 EMOTIONAL DISTRESS 5 0.0001
980 PSORIASIS 8 0.0001
981 SUICIDAL IDEATION 7 0.0001
982 DEVICE MALFUNCTION 3 0.0001
983 DRUG DOSE OMISSION 19 0.0001
984 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
985 ASCITES 2 0.0001
986 UNEVALUABLE EVENT 5 0.0001
987 ADVERSE DRUG REACTION 4 0.0001
988 MULTIPLE SCLEROSIS 3 0.0001
989 ACNE 4 0.0001
990 DELIRIUM 2 0.0001
991 INJECTION SITE ERYTHEMA 8 0.0001
992 INJECTION SITE PRURITUS 4 0.0001
993 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
994 MULTIPLE SCLEROSIS RELAPSE 4 0.0001